Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis.
Prachi BhaveLalit PallanGeorgina V LongAlexander M MenziesVictoria AtkinsonJustine V CohenRyan J SullivanVanna Chiarion-SileniMarta NyakasKatharina KahlerAxel HauschildRuth PlummerClaudia TrojanielloPaolo A AsciertoLisa ZimmerDirk SchadendorfClara AllayousCeleste LebbeAndrea MaurichiMario SantinamiSeverine RoyCaroline RobertThierry LesimpleSapna PatelJudith M VersluisChristian U BlankAdnan KhattakAndre Van der WesthuizenMatteo S CarlinoMark ShackletonAndrew M HaydonPublished in: British journal of cancer (2020)
Patients who relapse after adjuvant TT respond well to subsequent anti-PD-1 based therapy and have outcomes similar to those seen when first line anti-PD-1 therapy is used in stage IV melanoma.